Compounded Semaglutide to Tirzepatide: Unit Conversion & Syringe Guide
Dosage calculation guide for compounded GLP-1 medications. Convert syringe units (insulin U-100 syringes) to milligrams safely without dosing errors.
Clinical Rationale & Indications
Common Trigger: Transitioning through telehealth providers or 503A/503B compounding pharmacies.
Transitioning between different GLP-1 or dual GIP/GLP-1 receptor agonists alters gastric smooth muscle clearance rates and area postrema nausea pathways. Following structured conversion tables prevents acute vomiting, dehydration, and lean muscle catabolism.
Step-by-Step Dose Titration Matrix
Doctor-Reviewed Potency| Current Dose (Compounded) | Target Dose (Compounded) | Delay | Protein Floor | Protocol Guidance |
|---|---|---|---|---|
| Semaglutide 0.25mg (10 units @ 2.5mg/mL) | Tirzepatide 2.5mg (25 units @ 10mg/mL) | 30% | 1.8g/kg | Always verify vial concentration (mg/mL) before drawing medication. |
| Semaglutide 0.50mg (20 units @ 2.5mg/mL) | Tirzepatide 5.0mg (50 units @ 10mg/mL) | 40% | 1.9g/kg | Split protein into 4 equal 30g portions to eliminate gastric bloating. |
| Semaglutide 1.0mg - 2.0mg | Tirzepatide 7.5mg - 15.0mg | 55% | 2.1g/kg | Strict hydration requirement: minimum 3.2L water + electrolytes daily. |
Switching Doses Doubles Sarcopenia Catabolism
When transitioning to a new receptor agonist, sudden appetite suppression causes 40%+ of weight loss to be pulled from muscle. Audit your exact numbers free.
Frequently Asked Clinical Questions
Why do syringe units differ between Semaglutide and Tirzepatide?
Units measure liquid volume on an insulin syringe, NOT milligrams of drug. Because Tirzepatide requires higher milligram doses (e.g. 5mg vs 0.5mg), compounding pharmacies prepare it at different concentrations (e.g. 10mg/mL or 20mg/mL). Always check your vial label.